Esperavir® – the best lonch 2021 in a segment of the budgetary sales according to Iqvia Holdings, Inc

The production preparation Esperavir® Group of companies "Promomed" won first place in the category "The Best Lonch a Prescription Drug in a Segment of the Budgetary Sales in 2021" on Iqvia Holdings, Inc RXAndConsumerHealthAwards. The preparation Esperavir® developed by Group of companies "Promomed", became the winner of an award of Iqvia Holdings, Inc to RXAndConsumerHealth Awards which passes within annual action of Iqvia Holdings, Inc Client Day, in category "The best lonch a prescription drug in a segment of the budgetary sales in 2021. Winners in each nomination were defined on the basis of information from databases on preferential the medicinal...